We are live on ! Find out more
GSC

Ground Swell Capital Portfolio holdings

AUM $92.6M
1-Year Est. Return 41.64%
This Fund
S&P 500
This Quarter Est. Return
-1.3%
1 Year Est. Return
+41.64%
3 Year Est. Return
+71.08%
5 Year Est. Return
+78.79%
10 Year Est. Return
AUM
$129M
AUM Growth
+$19M
Cap. Flow
+$20.4M
Cap. Flow %
15.79%
Top 10 Hldgs %
74.11%
Holding
232
New
159
Increased
6
Reduced
7
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 6.64%
2 Healthcare 4.93%
3 Consumer Discretionary 3.07%
4 Consumer Staples 2.56%
5 Industrials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BURL icon
76
Burlington
BURL
$23.2B
$221K 0.17%
+921
New +$190K
EXAS
77
DELISTED
Exact Sciences
EXAS
$220K 0.17%
+5,205
New +$286K
RS icon
78
Reliance Steel & Aluminium
RS
$21.6B
$208K 0.16%
+727
New +$219K
NLY icon
79
Annaly Capital Management
NLY
$17.4B
$206K 0.16%
+10,782
New +$209K
VEEV icon
80
Veeva Systems
VEEV
$37.4B
$201K 0.16%
+1,098
New +$218K
CVX icon
81
Chevron
CVX
$366B
$200K 0.16%
+1,280
New +$204K
ARHS icon
82
Arhaus
ARHS
$1.36B
$183K 0.14%
+10,831
New +$175K
RIGL icon
83
Rigel Pharmaceuticals
RIGL
$750M
$141K 0.11%
+17,094
New +$179K
CMPX icon
84
Compass Therapeutics
CMPX
$387M
$124K 0.1%
+124,394
New +$182K
NG icon
85
NovaGold Resources
NG
$3.33B
$124K 0.1%
+35,814
New +$119K
LILA icon
86
Liberty Latin America Class A
LILA
$1.67B
$122K 0.09%
+18,672
New +$104K
UAA icon
87
Under Armour
UAA
$2.6B
$113K 0.09%
+16,884
New +$115K
INTT icon
88
inTEST
INTT
$177M
$112K 0.09%
+11,337
New +$121K
AUR icon
89
Aurora
AUR
$13.8B
$112K 0.09%
+40,336
New +$112K
TELL
90
DELISTED
Tellurian Inc.
TELL
$106K 0.08%
+153,750
New +$85.1K
QS icon
91
QuantumScape Corp
QS
$3.74B
$95.5K 0.07%
+19,410
New +$108K
NPKI
92
NPK International
NPKI
$1.14B
$91.2K 0.07%
+10,973
New +$84.5K
LICY
93
DELISTED
Li-Cycle Holdings Corp.
LICY
$88.6K 0.07%
+13,565
New +$74.9K
SGMT icon
94
Sagimet Biosciences
SGMT
$559M
$77.6K 0.06%
+22,687
New +$104K
SLDB icon
95
Solid Biosciences
SLDB
$900M
$76.4K 0.06%
+13,469
New +$121K
PLX icon
96
Protalix BioTherapeutics
PLX
$198M
$72.8K 0.06%
+62,234
New +$73.5K
PDSB icon
97
PDS Biotechnology
PDSB
$43.4M
$66.5K 0.05%
+22,700
New +$72.6K
MAIA icon
98
MAIA Biotechnology
MAIA
$86.3M
$56.3K 0.04%
+16,460
New +$51.9K
TELA icon
99
TELA Bio
TELA
$38.9M
$53.2K 0.04%
+11,319
New +$59.7K
BIAF icon
100
bioAffinity Technologies
BIAF
$3.2M
$49.4K 0.04%
+762
New +$52.8K

Similar funds

Ground Swell Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Ground Swell Capital held 232 positions worth $129M, up 17% from $110M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Ground Swell Capital deployed $20.4M of net new capital in Q2 2024, opening 159 new positions and adding to 6 existing holdings. Its largest new stake was Icon: 5,295 shares worth $1.66M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $32.8M trimmed.

  • Ground Swell Capital's largest Q2 2024 buy was Icon: 5,295 shares worth $1.66M.
  • Ground Swell Capital added most to iShares Russell 2000 ETF in Q2 2024, an estimated $15.6M increase.
  • Ground Swell Capital's biggest Q2 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $32.8M.
  • Ground Swell Capital fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $1.96M.
  • Ground Swell Capital's ten largest holdings make up 74% of its $129M portfolio in Q2 2024.
  • Ground Swell Capital opened 159 new positions and closed 59 in Q2 2024.
  • Ground Swell Capital's portfolio value rose 17% quarter-over-quarter to $129M.

Based on Ground Swell Capital's 13F filing for Q2 2024, filed 7 Aug 2024.